Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Zambon

Showing results (161-170 of 261) with videos related to

Pageof 27
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 5, 2021
Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020Anna Jeffery-Smith, Nalini Iyanger, Sarah V Williams, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 9, 2017
End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17Richard Pebody, Fiona Warburton, Joanna Ellis, et al.
BMJ (Clinical Research Ed.)|August 29, 2009
Monitoring the emergence of community transmission of influenza A/H1N1 2009 in England: a cross sectional opportunistic survey of self sampled telephone callers to NHS DirectAlex J Elliot, Cassandra Powers, Alicia Thornton, et al.
The Journal of Infectious Diseases|October 16, 2008
Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individualsAnn R Falsey, Edward E Walsh, Jose Capellan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2015
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirusDavide Corti, Jincun Zhao, Mattia Pedotti, et al.
The New England Journal of Medicine|July 21, 2021
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) VariantJamie Lopez Bernal, Nick Andrews, Charlotte Gower, et al.
Journal of Virology|October 21, 2011
Evolutionary dynamics of local pandemic H1N1/2009 influenza virus lineages revealed by whole-genome analysisGregory J Baillie, Monica Galiano, Paul-Michael Agapow, et al.
Nature Communications|December 5, 2023
Early mucosal events promote distinct mucosal and systemic antibody responses to live attenuated influenza vaccineRyan S Thwaites, Ashley S S Uruchurtu, Victor Augusti Negri, et al.
The Lancet. Healthy Longevity|December 7, 2021
Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in EnglandAnna Jeffery-Smith, Thomas A J Rowland, Monika Patel, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 30, 2016
Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season resultsRichard Pebody, Fiona Warburton, Joanna Ellis, et al.
Pageof 27

Showing results (161-170 of 261) with videos related to

Sort By:
Pageof 27
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 5, 2021
Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020Anna Jeffery-Smith, Nalini Iyanger, Sarah V Williams, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 9, 2017
End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17Richard Pebody, Fiona Warburton, Joanna Ellis, et al.
BMJ (Clinical Research Ed.)|August 29, 2009
Monitoring the emergence of community transmission of influenza A/H1N1 2009 in England: a cross sectional opportunistic survey of self sampled telephone callers to NHS DirectAlex J Elliot, Cassandra Powers, Alicia Thornton, et al.
The Journal of Infectious Diseases|October 16, 2008
Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individualsAnn R Falsey, Edward E Walsh, Jose Capellan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2015
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirusDavide Corti, Jincun Zhao, Mattia Pedotti, et al.
The New England Journal of Medicine|July 21, 2021
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) VariantJamie Lopez Bernal, Nick Andrews, Charlotte Gower, et al.
Journal of Virology|October 21, 2011
Evolutionary dynamics of local pandemic H1N1/2009 influenza virus lineages revealed by whole-genome analysisGregory J Baillie, Monica Galiano, Paul-Michael Agapow, et al.
Nature Communications|December 5, 2023
Early mucosal events promote distinct mucosal and systemic antibody responses to live attenuated influenza vaccineRyan S Thwaites, Ashley S S Uruchurtu, Victor Augusti Negri, et al.
The Lancet. Healthy Longevity|December 7, 2021
Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in EnglandAnna Jeffery-Smith, Thomas A J Rowland, Monika Patel, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 30, 2016
Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season resultsRichard Pebody, Fiona Warburton, Joanna Ellis, et al.
Pageof 27